TECX Insider Trading Activity and SEC Form 4 Filings
TECX insider trading summary
Over the past 12 months, insiders at Tectonic Therapeutic, Inc. (TECX) reported 11 sales worth $651K by 2 insiders and 2 open-market purchases worth $106K by 1 insider on SEC Form 4. Net insider selling was $546K.
Latest TECX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Peter McNamara | Chief Scientific Officer | Sell | $12K (536 @ $23.04) |
| Aug 25, 2026 | Peter McNamara | Chief Scientific Officer | Sell | $2K (43 @ $36.52) |
| Aug 12, 2026 | Peter McNamara | Chief Scientific Officer | Sell | $2K (43 @ $35.00) |
| Jun 30, 2026 | Peter McNamara | Chief Scientific Officer | Sell | $6K (172 @ $35.00) |
| May 4, 2026 | Marcella K. Ruddy | Chief Medical Officer | Sell | $32K (1,065 @ $30.00) |
| Apr 1, 2026 | Marcella K. Ruddy | Chief Medical Officer | Sell | $31K (1,000 @ $31.05) |
| Mar 6, 2026 | Peter McNamara | Chief Scientific Officer | Sell | $181K (6,047 @ $30.00) |
| Mar 6, 2026 | Peter McNamara | Chief Scientific Officer | Sell | $8K (215 @ $35.00) |
| Mar 6, 2026 | Marcella K. Ruddy | Chief Medical Officer | Sell | $300K (10,000 @ $30.00) |
| Mar 4, 2026 | Peter McNamara | Chief Scientific Officer | Sell | $41K (1,650 @ $25.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.